×

Alexion CEO: We are thrilled with FDA approval

8:18 AM ET Thu, 10 Dec 2015

CNBC's Meg Tirrell and David Hallal, Alexion Pharmaceuticals CEO, discuss the FDA's approval of the company's enzyme replacement drug Kanuma and weighs in on drug pricing.